Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01911130 · ClinicalTrials.gov registry record
Longitudinal Study of Outcomes Measures in ALS Trials
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 100
- Enrollment target
NCT01911130: Completed study, sponsored by Massachusetts General Hospital.
NCT01911130 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01911130 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
A new strength measurement device called Accurate Test of Limb Isometric Strength (ATLIS) was developed to precisely and conveniently measure static limb strength in patients with ALS. The investigators will compare ATLIS data with data from two commonly used ALS outcomes measures, the ALS Functional Rating Scale-Revised (ALSFRS-R) and slow vital capacity (SVC) in a prospective, longitudinal study. All three outcomes measures will be performed on 100 subjects collected preferably at bi-monthly clinic visits during the study period.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01911130
The ClinicalTrials.gov registry entry for NCT01911130 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01911130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01911130 about?
NCT01911130 is a clinical study titled "Longitudinal Study of Outcomes Measures in ALS Trials". A new strength measurement device called Accurate Test of Limb Isometric Strength (ATLIS) was developed to precisely and conveniently measure static limb strength in patients with ALS. The investigators will compare ATLIS data with data from two commonly used ALS outcomes measures, the ALS Functiona...
What is the current status of trial NCT01911130?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-07. Estimated completion is 2016-03.
Who is sponsoring clinical trial NCT01911130?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.